Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease

Published:2013-07-22 Issue:8 Volume:28 Page:1410-1415
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Sharma Haveesh¹²,Estep Michael³¹,Birerdinc Aybike¹²⁴,Afendy Arian³¹,Moazzez Amir³¹,Elariny Hazem³¹,Goodman Zachary³¹,Chandhoke Vikas¹²⁴,Baranova Ancha¹²⁴,Younossi Zobair M³¹

Affiliation:

1. Betty and Guy Beatty Center for Integrated Research; Inova Health System; Falls Church Virginia USA

2. Center for the Study of Chronic Metabolic Diseases; School of Systems Biology; College of Science, George Mason University; Fairfax Virginia USA

3. Center for Liver Disease; Department of Medicine; Inova Fairfax Hospital; Falls Church Virginia USA

4. Center for the Study of Chronic Metabolic Diseases; College of Science, George Mason University; Fairfax Virginia USA

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12268/fullpdf

Reference30 articles.

1. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome;Marchesini;Hepatology,2003

2. Liver pathology and the metabolic syndrome X in severe obesity;Marceau;J. Clin. Endocrinol. Metab.,1999

3. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults;Vernon;Aliment. Pharmacol. Ther.,2011

4. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease;Liu;Lipids Health Dis.,2010

5. Steatohepatitis: a tale of two “hits”?;Day;Gastroenterology,1998

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of the Key Genes Involved in Non-alcoholic Fatty Liver Disease and Possible MicroRNA Therapeutic Targets;Journal of Clinical and Experimental Hepatology;2024-07

2. Significance of MiRNA-34a and MiRNA-192 as a risk factor for nonalcoholic fatty liver disease;Journal of Genetic Engineering and Biotechnology;2023-12

3. miRNA Regulome in Different Atherosclerosis Phenotypes;Molecular Biology;2022-04

4. Circulating mir-200c and mir-33a may be used as biomarkers for predicting high fructose corn syrup-induced fatty liver and vitamin D supplementation-related liver changes;Turkish Journal of Medical Sciences;2022-01-01

5. Deciphering the role of epigenetic modifications in fatty liver disease: A systematic review;European Journal of Clinical Investigation;2021-01-04